The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002

Journal of the American Society of Nephrology

Volumn 16, Issue 1, 2005, Pages 210-218

  Foley, Robert N ^a   Li, Suying ^a   Liu, Jiannong ^a   Gilbertson, David T ^a   Chen, Shu Cheng ^a   Collins, Allan J ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; ETHNOLOGY; FEMALE; GENDER; HAZARD ASSESSMENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPARATHYROIDISM; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARATHYROIDECTOMY; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION; UNITED STATES; CHRONIC KIDNEY FAILURE; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY; RESOURCE ALLOCATION; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; STATISTICS;

AGED; COMORBIDITY; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PREVALENCE; RENAL DIALYSIS; RESOURCE ALLOCATION; RISK FACTORS; UNITED STATES;

EID: 20844447100     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004020138     Document Type: Article

References (23)

1. de Vernejoul MC, Kuntz D, Miravet L, Gueris J, Bielakoff J, Ryckewaert A: Bone histomorphometry in hemodialysed patients. Metab Bone Dis Relat Res 3: 175-179, 1981
2. Nilsson P, Melsen F, Malmaeus J, Danielson BG, Mosekilde L: Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis. Bone 6: 21-27, 1985
3. Ho LT, Sprague SM: Renal osteodystrophy in chronic renal failure. Semin Nephrol 22: 488-493, 2002
4. Cohen EP, Moulder JE: Parathyroidectomy in chronic renal failure: Has medical care reduced the need for surgery? Nephron 89: 271-273, 2001
5. Kestenbaum B, Seliger SL, Gillen DL, Wasse H, Young B, Sherrard DJ, Weiss NS, Stehman-Breen CO: Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int 65: 282-288, 2004
6. Tokuyama K, Iseki K, Yoshi S, Yoshihara K, Nishime K, Uehara H, Tozawa M, Wake T, Arakaki M, Fukiyama K: An epidemiologic analysis of parathyroidectomy in chronic dialysis patients. The Okinawa Dialysis Study Group. Nippon Jinzo Gakkai Shi 38: 309-313, 1996
7. Fassbinder W, Brunner FP, Brynger H, Ehrich JH, Geerlings W, Raine AE, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Combined report on regular dialysis and transplantation in Europe XX, 1989. Nephrol Dial Transplant 6[Suppl 1]: 5-35, 1991
8. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F: Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol 12: 1242-1248, 2001
9. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III: The rise and fall of primary hyperparathyroidism: A population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 126: 433-440, 1997
10. Vincenti F, Arnaud SB, Recker R, Genant H, Amend WJ Jr, Feduska NJ, Salvatierra O Jr: Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 25: 677-682, 1984
11. Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D: Renal osteodystrophy in diabetic patients. Kidney Int 44: 159-164, 1993
12. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrard DJ: Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321: 274-279, 1989
13. Llach F, Velasquez-Forero F: Calcium, phosphorus, renal bone disease and calciphylaxis. In: Therapy in Nephrology and Hypertension, 2nd Ed., edited by Brady HR, Wilcox CS, Philadelphia, WB Saunders, 2003, pp 701-712
14. Woodhead JS: The measurement of circulating parathyroid hormone. Clin Biochem 23: 17-21, 1990
15. Ritz E, Schomig M, Bommer J: Osteodystrophy in the millennium. Kidney Int Suppl 73: S94-S98, 1999
16. Elder G: Pathophysiology and recent advances in the management of renal osteodystrophy. J Bone Miner Res 17: 2094-2105, 2002
17. Slatopolsky EA, Burke SK, Dillon MA: RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group. Kidney Int 55: 299-307, 1999
18. Joy MS, Finn WF: Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: A new phosphate binder for the treatment of hyperphosphatemia. Am J Kidney Dis 42: 96-107, 2003
19. D'Haese PC, Spasovski GB, Sikole A, Hutchison A, Freemont TJ, Sulkova S, Swanepoel C, Pejanovic S, Djukanovic L, Balducci A, Coen G, Sulowicz W, Ferreira A, Torres A, Curic S, Popovic M, Dimkovic N, De Broe ME: A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int 63[Suppl 85]: S73-S78, 2003
20. Lindberg JS, Moe SM, Goodman WG, Coburn JW, Sprague SM, Liu W, Blaisdell PW, Brenner RM, Turner SA, Martin KJ: The calcimimetic AMG 073 reduces parathyroid hormone and calcium × phosphorus in secondary hyperparathyroidism. Kidney Int 63: 248-254, 2003
21. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S202, 2003
22. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
23. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15: 1014-1021, 2000